Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSAs we delve further into our series on obesity in the realm of Real-World Evidence (RWE), we transition from foundational considerations of data capture and ethical nuances to exploring the transformative power of technologies and the profound influence of socio-environments on obesity research. This continuation of our journey reflects the evolving nature of RWE and its critical role in addressing the multifaceted challenges of obesity. We will further unpack how digital tools and an understanding of broader societal factors enrich our insights into this global health issue.
In the evolving landscape of obesity research using RWE, digital apps and PROs have emerged as crucial elements. These tools are reshaping how data is collected and analyzed, offering new perspectives and deeper insights into the patient experience of obesity.
The rise of digital health technologies, particularly mobile apps, has opened up innovative avenues for collecting real-time, patient-generated data. These apps can track a wide range of data points relevant to obesity management, such as dietary intake, physical activity, medication adherence, and even sleep patterns. This data is invaluable in understanding the day-to-day experiences and challenges faced by individuals with obesity. Moreover, these apps can facilitate remote monitoring and virtual interventions, offering a dynamic and real-time picture of a patient’s progress and challenges in managing obesity.
PROs provide a direct lens into the patient’s perspective, offering insights into the effectiveness of treatments, quality of life, and the psychosocial impacts of obesity. Tools such as surveys, questionnaires, and digital platforms enable the collection of this valuable data. Incorporating PROs into RWE research enriches the data with subjective experiences that are often overlooked in clinical measures. This includes understanding the emotional and psychological dimensions of living with obesity, patient satisfaction with treatments, and the impact of obesity on daily functioning and well-being.
The integration of data from digital apps with PROs creates a uniquely powerful synergy in obesity RWE research. This synergy harnesses the strengths of both data types: digital apps provide objective, quantifiable data points on aspects such as physical activity, dietary patterns, and medication adherence, while PROs offer a window into the subjective experiences, perceptions, and impacts of obesity from the patient’s viewpoint.
This comprehensive approach allows researchers to construct a multi-dimensional picture of obesity. For example, while digital apps might indicate an increase in physical activity, PROs can reveal the motivational factors behind this change or the barriers patients face in maintaining an active lifestyle. Such a nuanced understanding is crucial for going beyond mere clinical parameters, offering a deeper dive into the real-world experiences of patients living with obesity.
In the evolving landscape of obesity research utilizing RWE, a comprehensive understanding of Social Determinants of Health (SDoH) is becoming increasingly recognized as essential. SDoH factors — encompassing economic stability, education access and quality, healthcare access and quality, neighborhood and built environment, and social and community context — are crucial in shaping the prevalence and management of obesity.
The integration of SDoH factors into RWE research offers profound insights into the broader context influencing obesity. By incorporating data on a patient's socioeconomic status, educational opportunities, living conditions, and access to healthcare, researchers can gain a more holistic view of the factors contributing to obesity. This data can be sourced from patient surveys, clinical interviews, healthcare system records, and increasingly, from digital health platforms that can provide contextual information on a patient's living environment and community resources.
Understanding how these social and environmental factors interplay with biological and behavioral aspects of obesity is key to developing more effective intervention strategies. For instance:
Analyzing how SDoH factors like payment options and healthcare access data are captured in RWD allows researchers to identify gaps in service provision. For instance, RWE can reveal whether individuals in lower-income brackets or without adequate insurance coverage are less likely to receive timely and effective obesity treatments. This understanding can spur policy changes aimed at improving healthcare access and affordability, thus enhancing obesity management outcomes.
Incorporating SDoH into obesity RWE research is not just about understanding the problem — it's about creating solutions that work. This approach allows for the development of treatment strategies and public health policies that are not only medically sound but also socially relevant and equitable. Tailoring interventions to address the specific SDoH factors affecting different populations can lead to more effective and sustainable outcomes in obesity management. Furthermore, the insights gained from SDoH-focused RWE research can be instrumental in informing public health policies and interventions. Policies that consider the social and environmental factors influencing obesity are likely to be more impactful and inclusive. This could involve initiatives aimed at improving community access to healthy foods, creating safer environments for physical activity, or addressing educational disparities that contribute to health knowledge gaps.
The future of obesity research through RWE is not only about harnessing emerging technologies but also about understanding and integrating new therapeutic approaches and the behavioral aspects of obesity management.
One of the most promising developments in obesity treatment is the advent of new pharmacotherapies, such as GLP-1 receptor agonists (GLP1-RA). These medications, originally developed for diabetes management, have shown significant efficacy in weight loss. The rapid access to these pharmacotherapy-based weight loss models marks a paradigm shift in obesity treatment. RWE plays a crucial role in monitoring the real-world effectiveness of these treatments, assessing long-term outcomes, and understanding patient adherence and response patterns. This is particularly important as the healthcare community moves towards more personalized approaches to obesity management, where treatments are tailored to individual patient profiles.
Additionally, the imperative to capture the behavioral aspects of obesity management is gaining increasing recognition in RWE research. This includes not only the obvious factors like mental health, nutritional habits, physical activity, and lifestyle choices, but also deeper insights into patients' social environments and mental states, which are integral to the management and prevention of obesity.
Technologies like Natural Language Processing (NLP) are becoming indispensable in this endeavor. NLP has the capability to extract nuanced information from unstructured data sources such as clinical notes. This includes identifying indications of a patient’s mental health state, social risks, and factors related to the social determinants of health (SDoH). For instance, NLP can help identify mentions of depression, anxiety, stress levels, or social issues like food insecurity and unstable living conditions from clinical narratives. This information is crucial in understanding the broader context of a patient’s obesity condition, facilitating a more comprehensive approach to treatment and management.
The integration of these advanced data collection methods and analytical tools in RWE research is not without its challenges but is essential for a thorough and nuanced understanding of obesity. By leveraging these technologies and methods, researchers can gain a deeper insight into the multifaceted nature of obesity, paving the way for more effective and personalized interventions.
In wrapping up this series, the role of RWE in informing and transforming obesity management on a global scale becomes increasingly significant. As we look towards the future, it's evident that RWE in obesity research holds transformative potential for policy and population-level health strategies. The insights gained through this comprehensive approach extend far beyond traditional clinical boundaries. They empower us to address the multifaceted challenges of obesity, considering not just medical aspects but also the broader societal and environmental factors. This holistic perspective is essential for developing interventions and policies that are truly effective and resonate with diverse populations.
The role of RWE in shaping public health initiatives cannot be overstated. It provides policymakers with a more nuanced understanding of the obesity epidemic, enabling the development of targeted, evidence-based strategies that can lead to meaningful public health improvements. By integrating technological advancements and fostering international collaboration, we can enhance our collective understanding of obesity and devise management strategies that are both effective and sustainable. Ultimately, this research paves the way for more informed, inclusive, and impactful health policies, ensuring that they align with the complex realities of the global population and lead to enduring public health benefits.See how observational health data sciences and informatics (OHDSI), a research collaborative with a global footprint, can expand data access and reduce cost of ownership.
